PIN60 Cost-Effectiveness of Telbivudine in First Line Treatment of Hbeag-Positive Patients with Chronic Hepatitis B (CHB) in the Turkish Health Care Setting
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.246
https://www.valueinhealthjournal.com/article/S1098-3015(11)01808-0/fulltext
Title :
PIN60 Cost-Effectiveness of Telbivudine in First Line Treatment of Hbeag-Positive Patients with Chronic Hepatitis B (CHB) in the Turkish Health Care Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01808-0&doi=10.1016/j.jval.2011.08.246
First page :
A276
Section Title :
Infection
Open access? :
No
Section Order :
226